HK CourtDB
HomeDirectoryMCP
Hong Kong CourtDB
Back to directory
Companies Winding-up Proceedings2006

LIN LESTER CHI KEE v. CHAN LEUK FU AND ANOTHER

Related cases with same parties

  • CACV282/2007LIN LESTER CHI KEE v. CHAN LEUK FU AND ANOTHER

Files (3)

72182-EN-2010-07-02

LIN LESTER CHI KEE v. CHAN LEUK FU AND ANOTHER

HTML content

HCCW 293/2006

IN THE HIGH COURT OF THE

HONG KONG SPECIAL ADMINISTRATIVE REGION

COURT OF FIRST INSTANCE

COMPANIES (WINDING-UP) NO. 293 OF 2006

____________

 

IN THE MATTER OF NU-WEST NATURAL PRODUCTS CORP. LIMITED (中國本草科學中葯有限公司)

 

and

 

IN THE MATTER OF SECTIONS 168A AND 177(1)(f) OF THE COMPANIES ORDINANCE, CAP. 32

____________

BETWEEN

 LIN LESTER CHI KEEPetitioner

and

 CHAN LEUK FU1st Respondent
 NU-WEST NATURAL PRODUCTS CORP. LIMITED2nd Respondent
____________

Before: Hon Barma J in Chambers

Date of Hearing: 8 December 2009

Date of Judgment: 2 July 2010

______________

J U D G M E N T

______________

 

1.  This was an application by Mr Chan Leuk Fu (“Mr Chan”), a contributory of Nu-West Natural Products Corp. Limited (“the Company”) for a stay of the winding up of the Company.

2.  Mr Chan is one of the two shareholders of the Company, the other shareholder being Mr Lester Lin Chi Kee (“Mr Lin”).  Each of them holds 50% of its issued shares.  In addition to being shareholders in the Company, Mr Chan and Mr Lin, both of whom live in the United States, are also interested in two American companies incorporated in the state of Washington, called Nu-West Natural Products Corp. (“Nu-West US”) and A-1 International Corp. (“A-1 International”).  Mr Lin has (some time ago) transferred his shares in Nu-West US to his son, but nothing turns on this for present purposes.

3.  The Company was ordered to be wound up by Kwan J (as she then was) on 3 August 2007, following the trial of a petition brought by Mr Lin, in which he sought (among other relief) the winding up of the Company on the just and equitable ground pursuant to section 177(1)(f) of the Companies Ordinance (Cap. 32), on the basis of allegations of wrongful conduct on the part of Mr Chan in respect of the Company which had caused the relationship between Mr Lin and Mr Chan to break down irretrievably.  Mr Darach Haughey and Mr Derek Lai of Messrs. Deloitte were subsequently appointed as its Joint and Several Liquidators (“the Liquidators”).  Prior to its liquidation, the Company’s main business was dealing in health products, principally pain relieving medicated pads sold under the name of “Riaxin”, supplied to it by Nu-West US.

4.  Apart from this petition, there was also litigation between Mr Chan and Mr Lin in the United States relating to Nu-West US and A-1 International.  This litigation continued after the conclusion of the winding up proceedings in Hong Kong.

5.  In November 2008, the parties to the United States proceedings embarked upon a mediation process, which resulted in their entering into a settlement agreement.  The agreement describes itself as having been made between Mr Chan and his “marital community”, Mr Lin, his wife and their “marital community”, Mr Lin’s son (to whom Mr Lin’s shares in Nu-West US had been transferred and his “marital community”, and Nu-West US, A-1 International and the Company.  The meaning of the expression “marital community” was not explained in these proceedings, but nothing appears to turn on it.  Although the agreement expressed itself as having been made by (among others) the Company, which was by then in liquidation, it does not appear that the Liquidators were involved in its negotiation, or approved its terms.  It therefore would not appear to be binding upon the Company or the Liquidators.

6.  The settlement agreement (which was signed by the various parties to it on 8 and 18 November 2008) contained the following main terms:-

(1)    Mr Chan was to pay, or cause any of the Company, Nu-West US or A-1 International, to pay a total of US$759,497 to the Lins.  This was to be paid in four instalments of US$50,000, US$209,497, US$250,000 and US$250,000 respectively (Clause 1).

(2)    Mr Lin and his son’s interests in the Company, Nu-West US and A-1 International were to be deemed to have been transferred to Mr Chan with effect from 1 June 2008, but such transfer was not required until the security referred to in the next paragraph had been provided (Clause 2).

(3)    As security for the full payment of the amounts stated in Clause 1, the parties were to create a mortgage or other charge over two properties in Hong Kong owned by the Company (workshop units in an industrial building in the New Territories) (“the Properties) to secure such payment until payment had been made in full (Clause 3).

(4)    The Lins were to waive any liabilities owed to them by the Company, Nu-West US and A-1 International, and would have no say over whether or not Mr Chan should repay to the Company, Nu-West US and A-1 International any sums which he might owe them (Clause 6).

(5)    The parties were to cooperate in taking such steps as might be necessary to rescind or otherwise nullify the winding up order against the Company (Clause 9).

7.  The settlement agreement appears to have been entered into without full regard to or appreciation of issues of Hong Kong law.  Thus:-

(1)    It does not seem to have been appreciated that as the Company was already in liquidation, it was no longer open to its shareholders and directors to make decisions in relation to it, and that it would be necessary to involve its liquidators in the settlement if it were to be one that could bind the Company;

(2)    No consideration appears to have been given to whether or not the terms on which the shares in the Company were to be transferred, in particular the provision by the Company of security over the Properties, complied with the provisions of the Companies Ordinance, which prohibit a company from providing financial assistance for the purpose of the acquisition of its own shares (sections 47A to 47G and 48 of the Ordinance).

8.  Some months after the settlement agreement was entered into, Mr Lin instructed his present solicitors.  They appear to have realised that there might be problems with the arrangements under the settlement agreement, particularly in relation to the requirements of section 47A of the Ordinance, and drew this to the attention of Mr Chan’s solicitors.  Although it initially seemed that Mr Chan’s legal advisers accepted that this was an issue that required to be addressed by making amendments to the settlement agreement before seeking to have the winding up of the Company stayed, in the end this did not happen.  Instead, Mr Chan and those advising him began to accuse Mr Lin of being obstructive, and took out the present application seeking a stay of the winding up, essentially on the basis that this had been agreed between the parties as part of the settlement agreement.

9.  At the hearing, Mr Raymond Tsui appeared for Mr Chan, Mr Bernard Man for Mr Lin and Ms Leung appeared for the Liquidators.  Mr Tsui sought an adjournment of the application pending a forthcoming hearing in the United States in relation to the settlement agreement.  The application was opposed, and having considered the arguments, I declined to adjourn the application, for reasons which I gave at the hearing.

10.  So far as the substantive application was concerned, this was opposed by Mr Lin.  Mr Man submitted that there were doubts as to the Company’s solvency, even if the settlement agreement were to be taken into account.  He went on to submit that the settlement agreement should not be taken into account, as it did not appear possible for it to be implemented in accordance with its terms, having regard to the fact that the intended security over the Properties would involve a breach of section 47A of the Ordinance.

11.  The Liquidators’ position was that provided that the Company was able to discharge all of its liabilities, including the costs of the liquidation, and was solvent at such time as the Liquidators might be discharged, they would adopt a neutral position in respect of the application.

12.  Mr Tsui submitted that, having regard to the terms of the settlement agreement, and the latest information as to the financial position of the Company, the Company was solvent, and that a stay of the winding up should be granted.  So far as the settlement agreement was concerned, he submitted that it was valid, and that the perceived problem in respect of section 47A of the Ordinance did not arise, as the situation was one which fell within one or other of two exceptions to the prohibition against the provision by a company of financial assistance to the purchase of its own shares.

13.  The power to order a stay of winding up proceedings arises under section 209(1) of the Ordinance, which provides that:-

“The court may at any time after an order for winding up on the application of … any contributory, and on proof to the satisfaction of the court that all proceedings in relation to the winding up ought to be stayed, make an order staying the proceedings, whether altogether or for a limited time, on such terms and conditions as the court think fit.”

14.  In Five Star Wine Limited (unreported, CFI, HCCW 1208/2002, 1 April 2003), I adopted as correct the approach of Megarry J to the equivalent English provision (section 256(1) of the Companies Act 1948) in Re Calgary & Edmonton Land Company Limited [1975] 1 All ER 1046.  Megarry J held (at pages 1051d to 1052a) that it was usually relevant to have regard to the interests of three groups of persons, namely the company’s creditors, its liquidators (who are entitled to be paid their costs, charges and expenses in priority to other claims) and, where there is likely to be a surplus, its members.  In Five Star Wine, the position was that the company’s realisable assets were less than its debts, but on the applicant for a stay undertaking to pay to the petitioner its outstanding debt and to pay to the liquidators an amount sufficient to cover their estimated costs, charges and expenses, I granted a stay conditional upon such payments being made, with the stay to take effect only after payment was made.

15.  It therefore seems to me that in considering the present application, the key question is whether or not the Company can be regarded as solvent.

16.  At the hearing, I was provided with a handwritten table that all parties agreed represented the current financial position of the Company.  This showed that there was cash on hand of some HK$1,572.943.41.  According to the Liquidators, no further significant recoveries were expected.  This was because remaining accounts receivable were likely to prove irrecoverable, and on the assumption that the settlement agreement would be put into effect, no value should be ascribed to the Properties, as they would stand charged to secure the payment of the agreed price for Mr Lin and his family’s shareholding in the Company and the two US companies, and similarly, no value should be ascribed to debts due from Mr Chan to the Company of some HK$3,165,938.47, as these were to be waived under the terms of the settlement.  Against this, the Company was liable to external creditors for some HK456,234.90 in respect of proofs of debt which had been accepted by the Liquidators, and the Liquidators costs and charges since their appointment were estimated at about HK$1 million, and were continuing to accrue.  In addition, there was a claim by Mr Chan, which had been admitted, in the amount of HK$210,000, but this could be left out if the settlement agreement were effective.  There were also debts of HK$63,000 to Mr Lin and HK$2,436,485.19 to Nu-West US, in respect of which proofs had been lodged, but which had not yet been adjudicated by the Liquidators.  Mr Tsui submitted that these, too, could be left out of account, assuming the settlement to be effective.

17.  Mr Man did not agree that the debt owing to Nu-West US should be left out of account, as the settlement agreement did not in terms call for a waiver of debts between the various companies inter se, but only as between the individuals (Mr Chan and Mr Lin) and the various companies.  To this submission, Mr Tsui responded that once the settlement was completed, Mr Chan would be in control of Nu-West US, and could therefore ensure that it waived the debt owed to it by the Company.

18.  Even assuming (without deciding) that the settlement agreement is valid and effective, and that all of the debts of Mr Chan, Mr Lin, the Company and Nu-West US can be ignored, the position at the hearing was that the Company had available cash of HK$1,572,000 odd, and debts and liquidation costs of about HK$1,456,000 odd.  Given that the amount of the liquidation costs was an estimate, and that additional costs would be incurred over time, I do not think that the court can be satisfied that the Company was in a position to meet all of its debts and liquidation costs so as to justify the exercise of the court’s discretion to grant a stay of the winding up proceedings.

19.  Further, in February 2010, after the conclusion of the hearing, Mr Chan’s solicitors wrote to the court to indicate that it was hoped that the matter could shortly be settled amicably.  This resulted in the Liquidators reiterating their position, and providing updated financial information, which indicated that the cash on hand was (which was more or less unchanged) now insufficient to meet the Company’s external debts (which remained at about HK$456,000) and the liquidation costs (which were estimated to have risen to some HK$1,600,000 odd, as a result of continued work done by the Liquidators and additional expenses which had been incurred).  Even allowing for the possibility that not all of the Liquidators’ costs would be recoverable on taxation of their bills, it would appear that the concern which I have mentioned in the previous paragraph has proven to be justified.

20.  Thus, even if the settlement agreement were valid and effective, and Mr Chan were to undertake that he would cause Nu-West US to waive its claims against the Company, the Company would now clearly not be able to meet all of its debts and liquidation costs.  Thus, in the absence of any arrangements being made to ensure that it will be able to do so, it would not be appropriate to order any stay of the winding up.

21.  It is therefore not strictly necessary to consider whether the provisions of the settlement agreement are valid and effective.  However, since Mr Tsui contended that it was, and the matter was argued, I shall briefly indicate my views on the matter.

22.  It seems to me that there is at the outset a difficulty in relation to the settlement agreement that arises from the fact that the Company is in liquidation.  For so long as that remains the case (i.e. until a stay of the winding up is granted), it would seem impossible for the security over the Properties called for under clause 3 of the settlement agreement to be granted without the agreement of the Liquidators.  Given the Company’s financial position, it is not easy to see how such agreement would be forthcoming.  In those circumstances, the obligation on Mr Lin and his family’s part to transfer their interests in the Company and the two United States companies would also remain in abeyance, and it would not seem possible for the arrangements under the settlement agreement to be completed.

23.  Further, so far as the question of section 47A of the Ordinance is concerned, that section prohibits the giving of direct or indirect financial assistance by a company for the purpose of the acquisition of shares in itself.  In the context of the settlement agreement, the provision by the Company of security over the Properties to secure the payment of the purchase price in respect of its (and the United States companies’) shares would clearly amount to the provision of financial assistance to Mr Chan to enable him to acquire such shares (see e.g.Heald v O’Connor [1971] 1 WLR 497).  This was not disputed by Mr Tsui.

24.  Mr Tsui suggested, however, that the situation came within the exception to section 47A provided by section 47C(1)(a), which states that financial assistance is not prohibited if the company’s principal purpose in giving that assistance is not to give it for the purpose of any such acquisition, or the giving of the assistance is but an incidental part of some larger purpose of the company.  Mr Tsui submitted that in this case, as the provision of the security was part of the arrangements to settle overall the disputes between Mr Chan and Mr Lin, the giving of the assistance in the form of the security was but an incidental part of some larger purpose of the Company.

25.  However, in Brady v Brady [1989] AC 755, the House of Lords held that a distinction must be drawn between the purpose for which a company gives financial assistance and the reason or motive for doing so.  As Lord Oliver put it (at 779E to 780H):-

“… if the [prohibition] is not, effectively, to be deprived of any useful application, it is important to distinguish between a purpose and the reason why a purpose is formed. The ultimate reason for forming the purpose of financing an acquisition may, and in most cases probably will, be more important to those making the decision than the immediate transaction itself. But “larger” is not the same thing as “more important” nor is “reason” the same as “purpose”. … The purpose and the only purpose of the financial assistance is and remains that of enabling the shares to be acquired and the financial or commercial advantages flowing from the acquisition, whilst they may form the reason for forming the purpose of providing financial assistance, are a by-product of it rather than an independent purpose of which the assistance can properly be considered to be an incident.

… the only purpose that can be discerned in the redemption of loan stock is the payment in tangible form of the price payable to enable the Brady shares to be acquired … to say that the “larger purpose” of Brady’s financial assistance is to be found in the scheme of reorganisation itself is to say only that the larger purpose was the acquisition of the Brady shares on its behalf. … The acquisition was not a mere incident of the scheme devised to break the deadlock. It was the essence of the scheme itself and the object which the scheme set out to achieve.”

26.  I agree with Mr Man that this case is not relevantly distinguishable from the situation in Brady v Brady, as the purpose of providing the financial assistance here, in the form of the security to be granted, was to enable Mr Chan to acquire (inter alia) the shares in the Company.  Without such security, Mr Lin might well not be willing to part with his shares in the Company in advance of full payment of the price, as was envisaged by the settlement agreement.  The desire to settle the disputes between the parties was the reason why the parties wished to have Mr Lin sell his interests in the Company and the two United States companies to Mr Chan, but the purpose of the financial assistance was to enable that sale to take place.

27.  Mr Tsui suggested that the situation in this case was distinguishable, because here, the Company was already in liquidation.  However, I am unable to see that this provides a relevant distinction either – in Brady v Brady, it was desired to prevent the companies concerned from being wound up, whereas here, it is desired to remove the Company from liquidation and return it to a situation in which it can resume business.  In both situations the objective is to avoid a situation in which the company is (or remains) in liquidation, so that it can carry on business.

28.  Mr Tsui suggested in the alternative that it might be possible to come within the relaxation of section 47A available to unlisted companies under section 47E(1), which provides that financial assistance is not prohibited if the provisions of the rest of that section, and sections 47F to 48 are complied with.  One of the requirements is that contained in section 47E(6), which requires that a majority of the directors of the company proposing to give the financial assistance should have a statement complying with section 47F before the financial assistance is given.  Section 47F requires that the directors giving the statement state (among other things) that they have formed the opinion that, as regards the company’s initial situation immediately following the date on which assistance is proposed to be given, that there will be no ground on which it could then be found to be unable to pay its debts and that it will be able to pay its debts as they fall due during the year immediately following that date.

29.  Mr Man submits that it Mr Lin would be acting entirely reasonably in declining to make such a statement, having regard to the Company’s present financial position, particularly as the making of such a statement without reasonable grounds for doing so would expose him to the risk of committing an offence under section 47(5), which would be punishable by a fine or imprisonment.  Given the Company’s financial position as I have set it out above, I think that this must be right.

30.  Accordingly, it would not seem that the Company would be able to bring itself within any of the available exceptions so as to render the giving of the financial assistance lawful, and it would not therefore seem possible for the settlement agreement to be implemented according to its terms as things stand.  That being so, the reason for the stay application would appear to fall away, and it was not, I think, suggested by Mr Tsui that the application could succeed in those circumstances.

31.  Thus, for the reasons which I have given, I have come to the view that the application must be dismissed.  So far as the costs of the application are concerned, I shall make an order nisi that Mr Lin’s and the Liquidators’ costs of the application should be paid by Mr Chan, to be taxed on the party and party basis if not agreed.

(Aarif Bama)
Judge of the Court of First Instance
High Court

Mr. Bernard Man instructed by Messrs Simmons & Simmons,for the Petitioner

Mr. Raymond Tsui instructed by Messrs K.Y. Lo & Co. for the 1st Respondent

Miss Leung Wai Po of Messrs ONC Lawyers for the Joint & Several Liquidators

Attendance excused for Official Receiver  

58079-EN-2007-08-03

LIN LESTER CHI KEE v. CHAN LEUK FU AND ANOTHER

HTML content

HCCW 293/2006

IN THE HIGH COURT OF THE

HONG KONG SPECIAL ADMINISTRATIVE REGION

COURT OF FIRST INSTANCE

COMPANIES (WINDING-UP) NO. 293 OF 2006

______________________

 IN THE MATTER OF NU-WEST NATURAL PRODUCTS CORP. LIMITED (中西本草科學中葯有限公司)
 and
 IN THE MATTER of Sections 168A and 177(1)(f) of the Companies Ordinance, Chapter 32 of the Laws of Hong Kong Special Administrative Region

BETWEEN

 LIN LESTER CHI KEEPetitioner
 and 
 CHAN LEUK FU1st Respondent
 NU-WEST NATURAL PRODUCTS CORP. LIMITED2nd Respondent

______________________

 

Before : Hon. Kwan J. in Court

Dates of Hearing : 9 to 12 and 16 July 2007

Date of Handing Down of Judgment :  3 August 2007

 

______________________

J U D G M E N T

______________________

 

1.  This is a petition presented by Lin Lester Chi Kee to wind up Nu-West Natural Products Corp. Limited (“the Company”; 中西本草科學中藥有限公司) on the just and equitable ground, pursuant to section 177(1)(f) of the Companies Ordinance, Cap. 32.  Alternatively, the petitioner seeks an order that Chan Leuk Fu, the 1st respondent herein, should buy out his shares at a fair value to be determined by an independent valuer appointed by the court, pursuant to section 168A of Cap. 32.  The petitioner and the 1st respondent are the only shareholders of the Company, each holding 50% of the issued shares.  They are also the only directors.

2.  There are two supporting creditors to the petition, Fan Chi Shing and Madam Chan Pik Lin Berry (“Madam Chan”).  Both are former employees of the Company.  Mr. Fan has obtained an award in his favour in the Labour Tribunal.  Madam Chan has a claim for arrears in wages.  They did not take part in the hearing.

3.  The 1st respondent was legally represented until three weeks before trial, when he filed a notice to act in person.

4.  Other than the petitioner and the 1st respondent, Madam Leung Lin Wan Winnie (“Madam Leung”) was the only witness who had testified at the trial.  Madam Leung is a former employee and she gave evidence for the petitioner.  The petitioner has filed affirmations of two witnesses who are abroad, Dr. Enyou Yu and Madam Wei Zhang.  As the 1st respondent had indicated by his former solicitors that he would not wish to cross-examine them, their affirmations were admitted into evidence without the need of calling them.  One other deponent for the petitioner, Gerald Thomason, was required to be called by the 1st respondent.  Mr. Samuel Chan, who appeared for the petitioner, informed the court that Mr. Thomason, who also resides abroad, would not be called and his affidavit would not be relied on.

The background matters

5.  The Company was incorporated in Hong Kong on 17 May 2000.  The authorised share capital is HK$10,000.00, all of which were issued and paid up.

6.  The name of the Company in English and Chinese closely resembles that of a company set up by the petitioner and the 1st respondent on 7 October 1998 in the state of Washington in the United States, known as Nu-West Natural Products Corp. (“Nu-West US”; 中西本草股份公司).  The petitioner and the 1st respondent are residents of Seattle at all material times.

7.  Prior to setting up Nu-West US, the petitioner and the 1st respondent had engaged in the following co-operative business ventures:

(1)On 15 June 1995, they incorporated A-1 International Corp. (“A-1 International; 大利國際公司) in the state of Washington, owned by them in equal shares.  For about six months from late 1995 to early 1996, they exported new and used cars from the United States to Hong Kong and Mainland China through this company.  The petitioner was the president of A-1 International and the 1st respondent the vice president.  According to a co-operation agreement in Chinese drawn up by the 1st respondent dated 28 May 1995, the petitioner was responsible for providing capital and managing finance and the 1st respondent was responsible for business operation and management.
(2)During 1996 to 1997, they participated in a software business venture in Indonesia through A-1 International, with two individuals in Taiwan, Mr. Pan and Mr. Ong.  The petitioner was the managing director of this business venture and the 1st respondent was the assistant to the managing director.
(3)On 24 August 1997, the petitioner signed a distributorship agreement on behalf of A-1 International with Libest International Corporation (“Libest”), a manufacturer of pain-relieving pads known as “Libest Spur Effect” (百事達骨刺靈).  Libest was established by an individual from Mainland China and was looking for an agent in Seattle for distribution of its pain-relieving pads.  The petitioner invested US$40,000.00 into A-1 International for this distributorship business, which continued for about two years until September 1999.
(4)On 23 March 1998, the petitioner, the 1st respondent and Dr. Enyou Yu set up CYL International Corp. (“CYL”; 大恩堂草本研究中心) to research, develop, produce and distribute proprietary herbal medicine.  In the co-operation agreement in Chinese drawn up by the 1st respondent of that date, it was provided that the petitioner was the managing director, responsible for finance and personnel management; the 1st respondent was the general manager, responsible for business and marketing; and Dr. Yu was responsible for the research and manufacturing of new medicine.  The petitioner put up the capital for this business.  He held 34% of the shares, the 1st respondent and Dr. Yu each held 33%.  CYL was dissolved by mutual agreement of the petitioner, the 1st respondent and Dr. Yu on 20 September 1999.

8.  In the course of distributing pain-relieving pads for Libest, the petitioner and the 1st respondent set up Nu-West US in October 1998, to manufacture and market their own brand of pain-relieving pads known by the brand name of “RIAXIN” (骨痛傷腫特效靈).

9.  There is some dispute when RIAXIN was successfully developed and whether the petitioner had played any part in its research and development.  The 1st respondent claimed that he alone successfully invented the formula for RIAXIN in August 1998 and allowed the petitioner to share in the fruits of his success.  The petitioner accepted initially in the petition that the formula was created in mid 1998.  In his subsequent affirmations, he claimed that RIAXIN was being developed in the summer of 1998, it was a collaborative effort and he had made contributions in doing extensive research on herbal medicine.  He exhibited correspondence and documents to show that RIAXIN was successfully developed some time after August 1999.  He made enquiries with his cousin Madam Wei Zhang in China and she had found for him various sets of encyclopaedia on Chinese herbs, many periodicals and journals and a directory of manufacturers of medicine in China.

10.  At the outset, the petitioner and the 1st respondent each held 50% shares in Nu-West US.  They were the incorporators and the first directors.  The general nature of the business, as provided in the articles of association, is the research, manufacturing, marketing, import and export of herb and health food.  All of the petitioner’s shares have been transferred to his son Richard Lin (“Richard”).  The petitioner claimed that the transfer took place soon after the incorporation of the company, as the parties thought it was too risky that the shareholders were identical to A-1 International, in case Libest should sue for misappropriation of trade secrets.  The 1st respondent asserted that he had no knowledge that Richard is a shareholder until his relationship with the petitioner turned sour in February 2006.  The petitioner, Richard and the 1st respondent are the directors of Nu-West US.

11.  In late 1999, the petitioner and the 1st respondent decided to expand the market of RIAXIN pads manufactured by Nu-West US to Asia, including Hong Kong, Taiwan and Mainland China.  In January and March 2000, the petitioner caused Nu-West US to remit a total of US$2,500.00 to Madam Chan, a friend of the 1st respondent, to cover her expenses in setting up the Company in Hong Kong for selling RIAXIN products.  The Company was incorporated in May 2000.

12.  The sales volume of the Company in 2000 was small.  It operated from the home of Madam Chan at the time.  In March 2001, the petitioner, the 1st respondent and Richard decided to expand the business of the Company and invest further capital to secure business premises for the Company.  Nu-West US remitted a total of US$25,000.00 for this purpose in March and April 2001.  The 1st respondent opened a bank account for the Company in Hong Kong and, with the agreement of the petitioner, he and Madam Chan were appointed alternate authorised signatories.

13.  Madam Chan was appointed the general manager of the Company in April 2001.  The 1st respondent divided his time between the United States and Hong Kong and spent half of his time in Hong Kong to look after the business here.  The petitioner took care of the business of Nu-West US.  The 1st respondent received a salary from both Nu-West US and the Company.  The petitioner received a salary from Nu-West US only.  It is common ground that the 1st respondent had reported to the petitioner the sales of the Company on a daily basis and sent him the accounts every month.  All the RIAXIN pads sold by the Company were manufactured in the United States by Nu-West US.  The Company was not engaged in production of the pads.

14.  For the period from incorporation to August 2002, the Company made a profit after tax of HK$1.9 million.  Using the profits earned, in July 2002, the Company purchased Workshop 9 on 8th Floor, Wah Wai Centre, Nos. 38 to 42 Au Pui Wan Street, Fotan, Shatin, New Territories (“the 8th Floor property”) for HK$1,200,000.00.  This became the registered office of the Company.  Profit after tax from September 2002 to December 2003 was HK$2.4 million.  In May 2003, part of the profit was used to purchase another property in the same building, Workshop 10 on 9th Floor (“the 9th Floor property”), as business premises for the Company, for HK$750,000.00.  In March and April 2004, a third property in the same building, Workshop 10 on 10th Floor (“the 10th Floor property”), was purchased for HK$780,000.00.  However, this time, the 10th Floor property was assigned to the 1st respondent as the purchaser.  The Company had used the 10th Floor property as a warehouse for a period; otherwise it was left vacant.  The 1st respondent did not require the Company to pay for the use of this property.

The breakdown of co-operation and matters leading to the petition

15.  It is common ground that the relationship of co-operation between the petitioner and the 1st respondent has broken down completely and this came about in February 2006.  The parties’ differences as to how the businesses of the Company and Nu-West US should be run were triggered by the incidents arising out of the Hong Kong Brands and Products Expo held in Hong Kong in December 2005 to early January 2006.  Nu-West US invested about HK$330,000.00 in the Expo, which was attended by the petitioner and Richard.  The petitioner prepared a detailed evaluation of the Expo in January 2006.  The 1st respondent however regarded the Company’s participation in the Expo as an outright failure.

16.  The salient incidents before and after the breakdown of relationship, based on undisputed evidence or contemporaneous documents, were as follows:

(1)On 7 February 2006, there was a meeting between the petitioner, Richard and the 1st respondent at the latter’s home in Seattle.  The 1st respondent accused Richard of being keen to spend money on the Expo and claimed it did not generate results.  He expressed discontent with the marketing strategies, personnel and research proposal of the petitioner and Richard.
(2)On 8 February 2006, the 1st respondent sent a long fax to the petitioner in which he stated that projects of Nu-West US which would involve spending must cease immediately and if money had to be spent, a plan should be submitted for his prior approval. As for the Company, the 1st respondent asked the petitioner not to interfere as this would disturb his strategies and tactics in a critical period.  He sought to draw a clear distinction between shareholders’ power and executive power, and asserted that although the ‘executive shareholder’ should be responsible to all shareholders, the power exercised by the ‘executive shareholder’ was “inviolable”.  He hinted at his preference that the parties should go their separate ways.
(3)On 27 March 2006, without prior discussion with the petitioner, the 1st respondent caused the Company to place a substantial purchase order with Nu-West US for 500 cartons of RIAXIN pads, with no shipment date or schedule.  The petitioner responded by fax on the same day that the existing production capacity could only supply an initial shipment of 200 cartons by early May 2006, and the balance would have to be postponed.
(4)In the 1st respondent’s fax on 29 March 2006, he insisted that the Company must have three months’ stock to meet the anticipated boost in business from April 2006.  He stated that if Nu-West US could not act accordingly, he would prepare for production in Hong Kong, which would save time, energy and expenses.
(5)The 1st respondent reiterated in his fax to the petitioner on 3 April 2006 that the Company must have three months’ stock and accused the petitioner of being irresponsible in not specifying how long the delivery of the balance would be postponed.  The petitioner replied on the same day by a long fax, at the end of which he asked the 1st respondent to consider liquidating the assets and liabilities of the operation in Hong Kong and let him take back his equity of 50% and withdraw from the Company, as the 1st respondent did not appear to trust him any more.
(6)In his fax to the petitioner dated 9 April 2006, the 1st respondent proposed a division of assets as follows: the petitioner should own Nu-West US and he should own the Company, and they would use 31 March 2006 as the cut-off date.  The net asset value of both companies would be calculated and after setting off the amounts due, they would make arrangements for payment of the balance.  He enclosed his calculation of the net asset value of the Company and requested the petitioner to do likewise for Nu-West US.  They could then discuss other issues in respect of Nu-West US, including the use of trademarks, production technologies, product formula, intellectual property and market distribution.
(7)As the 1st respondent did not hear from the petitioner on his proposal for splitting up, he chased for a reply on 18 April 2006.
(8)On 22 April 2006, the petitioner informed the 1st respondent by fax that after consideration, he would not sell his shares in the Company.
(9)Before the 1st respondent received the petitioner’s reply, he had already given instructions to an information technology company, Friends Marketing Ltd., to design a website with the domain name of www.chanspainpad.com, to promote pain-relieving pads similar to RIAXIN, as evidenced by a fax of one Mr. Chan of Friends Marketing Ltd. dated 21 April 2006.  According to an e-mail of Mr. Chan to Madam Chan dated 8 May 2006, it was requested that all visits to the website of the Company at www.riaxin.com.hk would be re-directed to www.chanspainpad.com.  On or about 25 April 2006, HK$17,600.00 was drawn out of the Company’s bank account to pay the registration fee of the new website and for diverting all web searches for RIAXIN and its name in Chinese to the new website.  Madam Chan engaged Huyi Global Information Resources (Holding) Co. Hong Kong Ltd. to register four Chinese Internet search keywords (中西本草, 骨痛, 傷痛, 特效靈) corresponding to www.chanspainpad.com.
(10)On 25 April 2006, the 1st respondent instructed his accountant in the United States to use the “fastest method” to set up a new company in the state of Washington by the name of New West Natural Products Corp. (U.S.A.) (“New West US”), with himself as the sole proprietor, to produce and export herbal products.  New West US was incorporated on 26 April 2006 with the 1st respondent as the sole shareholder and president.  He chose the name New West, as this was similar to the names of Nu-West US and the Company.
(11)At about the same time, the 1st respondent placed orders with various suppliers to purchase ethyl alcohol and bandage adhesive plasters for the production of pain-relieving pads.  In his letter dated 26 April 2006 to Madam Wong Yim of Firstar Healthcare Co. Ltd., a supplier in Guangzhou, China, he asked the materials to be delivered to his new company in Seattle and he would use the name of the Company to place the order and make payment.  He requested Madam Wong to contact Madam Chan for all things and to communicate by telephone or fax for the time being instead of by e-mail, as the website might link up with Nu-West US and was “not advantageous for keeping secret”.  The materials ordered from various suppliers were paid for with the funds of the Company.
(12)On 28 April 2006, the 1st respondent entered into a formal sale and purchase agreement to sell the 10th Floor property for HK$1,200,000.00.  He assigned the property to the purchaser on 29 May 2006 and kept the net proceeds of sale for his own use.
(13)Also on 28 April 2006, the 1st respondent unilaterally increased his salary in the Company from HK$40,000.00 a month to HK$100,000.00 and withdrew the said sum from the Company’s bank accounts.
(14)On 7 May 2006, the 1st respondent instructed Madam Chan to remit US$100,000.00 from the bank account of the Company to his personal account in the United States.  She was instructed to enter the said sum in the accounts of the Company as payment in advance for the goods to be supplied by New West US.  The sum was remitted the following day.  Goods already delivered by Nu-West US to the Company, for which over HK$2.1 million was owed, remained unpaid since April 2006.
(15)On 17 May 2006, the 1st respondent purchased two sealing machines for New West US at HK$8,392.00 with the funds of the Company.
(16)The petitioner caused Nu-West US and the Company to bring proceedings in the United States against the 1st respondent and New West US on 18 May 2006 for breach of fiduciary duty, misappropriation of trade secrets, breach of contract, conversion, conspiracy and unfair trade practice.  A temporary restraining order was obtained against the defendants ex parte on 19 May 2006 and was discharged on 1 June 2006.
(17)The petitioner came to Hong Kong and on 19 May 2006, he terminated the employment of Madam Chan and her daughter summarily and changed the locks of the office afterwards.  A set of the new keys was provided to the 1st respondent on 25 May 2006 when he went to the office with Madam Chan and others and attempted to expel the petitioner.  The police was called on both occasions.  Madam Chan and the 1st respondent refused to provide the petitioner with the password of the Company’s account for Internet banking, and removed all the cheque books on 29 May 2006.  The petitioner was unable to use the funds of the Company to pay wages of its staff or other creditors.
(18)On 30 May 2006, the 1st respondent terminated the employment of Madam Leung and Miss Ng Yee Ching, who had assisted the petitioner.
(19)On 1 June 2006, the 1st respondent’s solicitors wrote to the petitioner demanding an undertaking that he should not tamper with, interfere in, or disrupt the business and day to day operation of the Company.
(20)On 3 June 2006, the 1st respondent caused three notices to be posted up in the office of the Company.  They were headed “Company Announcement”, “Causes of Disputes between Shareholders”, and “Partnership Law – Limited Partnerships”.  He also sent copies of the notices to the petitioner.  The Company Announcement dated 1 June 2006 was issued by the 1st respondent as “executive director”.  In it he stated that the petitioner was just an ‘ordinary shareholder’, not an ‘executive shareholder’ unlike him, who alone was entitled to ‘the right of execution’ in the Company.  He announced to the employees that they could refuse to perform any assignment given by the petitioner; they could refuse the petitioner’s request for the Company’s cheques, seal, accounts and documents; they could refuse to tell the petitioner the passwords to the Company’s computers, bank accounts or electronic gates.
(21)On 5 June 2006, the 1st respondent changed the locks of the office of the Company and did not provide the petitioner with a set of the new keys.
(22)In June 2006, funds were drawn from the Company’s bank account to pay for various items for the production of pain-relieving pads by New West US: inner aluminium pouches, another sealing machine, bandage adhesive plasters, computer software design, installation and miscellaneous charges.
(23)The petitioner’s solicitors wrote to the 1st respondent’s solicitors on 7 June 2006 demanding an account of the monies withdrawn from the Company’s bank accounts and an account of the proceeds of sale of the 10th Floor property.

17.  This petition was presented on 13 June 2006.  The 1st respondent issued a summons on 19 June 2006 seeking a validation order in respect of payments made into or out of the bank accounts of the Company in the ordinary course of business and dispositions of the property in the ordinary course of business for proper value.  I dismissed his application on 28 June 2006.

The broad issues in dispute

18.  The broad issues in dispute may be stated as follows:

(1)whether the Company was set up as a marketing arm of Nu-West US in Asia on the basis of mutual trust and confidence similar to Nu-West US and other business ventures previously set up by the petitioner and the 1st respondent, or whether it was set up as an entirely separate company free to pursue its own interest without regard to Nu-West US (“the quasi-partnership issue”);
(2)whether the petitioner has been unjustifiably excluded from the management of the Company by the 1st respondent since about February 2006 (“the expulsion issue”);
(3)whether the 1st respondent has misappropriated the funds of the Company for the purpose of setting up a rival company in the United States owned or controlled by him, New West US, after the split-up negotiations between the petitioner and the 1st respondent had fallen through in April 2006, or whether the 1st respondent was justified in setting up New West US (“the misappropriation issue”);
(4)whether the 10th Floor property and the sales proceeds thereof upon its sale in May 2006 were held by the 1st respondent on trust for the Company (“the 10th Floor property issue”), or whether the 10th Floor property was purchased with the 1st respondent’s own funds for his own benefit; and
(5)if the petitioner should succeed in establishing his case, what is the appropriate relief that should be granted (“the relief issue”).

19.  Other matters of dispute were raised in evidence.  I do not consider them relevant and it is not necessary for present purpose to resolve them.

The witnesses

20.  The principal witnesses are the two protagonists, who, between them, have filed a total of nine affirmations in these proceedings.  From the above findings of salient matters resulting in the breakdown of relationship, based on matters largely not in dispute, the 1st respondent would need to explain and justify his actions, namely, his exclusion of the petitioner from the management of the Company, his setting up of New West US in a secretive manner to produce pain-relieving pads similar to the RIAXIN pads produced by Nu-West US, and his use of the Company’s moneys to fund the operations of New West US.

21.  The 1st respondent’s cross-examination of the petitioner was relatively brief, centred mostly on peripheral matters of little relevance to the real issues in dispute.  The petitioner’s counsel cross-examined the 1st respondent extensively and I have had ample opportunity to assess his credibility.

22.  The 1st respondent is seventy years old.  As is apparent from the letters, the petitioner had for a long time looked up to the 1st respondent, as the older of the two men, with greater experience and learning.  The 1st respondent’s name in Chinese is陳畧呼 (Chan Leuk Fu).  He is usually known by the name of陳大夫 (Chan Dai Fu), “dai fu” meaning a practitioner in Chinese medicine.  He is not conversant in English.

23.  The impression I have of the 1st respondent is that he is a crafty, opportunistic and manipulative person.  He is capable of dubious and underhand practice, as is evident from a letter dated 10 September 1997 he wrote to Mr. Pan and Mr. Ong, less than a month of the appointment of A1-International as a distributor of Libest Spur Effect, informing these business partners from Taiwan that he had solved the skin allergy problem caused by the Libest pads and proposed to launch his own brand of pain-relieving pads.  He suggested that before he was able to develop the new medicine, they could build up the new brand in Taiwan by using the Libest pads and re-packaging the pads with the new brand name, to open up the market and accumulate enough capital for the new business venture.  The plan was to be carried out in the names of the Taiwan partners so that Libest would not suspect A-1 International’s involvement and stop the supply under the distributorship agreement.  The petitioner deposed in his affirmation that this plan was rejected by him and the Taiwan partners as “devious” and was not implemented.  The 1st respondent retorted in his affirmation this was an attempt to smear his character but his letter speaks for itself.

24.  The petitioner is a more straightforward person.  I am inclined to accept his evidence on most matters.

The quasi-partnership issue

25.  The petitioner’s case is that the Company was set up as a continuation of the previous quasi-partnership between him and the 1st respondent in Nu-West US, arising out of their decision to expand the business of RIAXIN pads into the Asian markets.

26.  In cross-examination, the 1st respondent accepted that the Company and all the other business ventures were formed on the basis of mutual trust and confidence between him and the petitioner.  Further, in his long fax to the petitioner on 8 February 2006, he stated that the Hong Kong and American companies “are one body”.  This understanding was also reflected in a business analysis prepared by the 1st respondent and faxed to the petitioner in about July 2001, in which reference was made to the consolidated profit and loss position of Nu-West US and the Company.

27.  I have no difficulty in finding that both Nu-West US and the Company were in the nature of quasi-partnerships formed on the basis of mutual trust and confidence between the petitioner and the 1st respondent.  There was close collaboration between them in setting up these entities.  The participation of both in the development of the formula for RIAXIN was the genesis of their quasi-partnership in Nu-West US and the Company.  For present purpose, it is not necessary to decide who invented the formula.  At the very least, I find on the evidence adduced by the petitioner and of Madam Wei Zhang that he had played some part in the development and research of the formula.  The extent of his involvement was mentioned in his letter to the 1st respondent dated 18 March 2006, and was not disputed by the 1st respondent in the correspondence exchanged at the time.

28.  I reject the 1st respondent’s evidence that the petitioner only became involved in the development of the formula in March 2000, when he asked the petitioner to order the ingredient Glycerin.  This was not borne out by the documents adduced by the petitioner, which showed that he had a greater involvement and it was earlier than March 2000.  The 1st respondent’s assertion that he alone was responsible for developing the formula with his own financial resources and that he had allowed the petitioner to share in the fruits of his hard work is not credible.

29.  I find also on the evidence that the petitioner had taken an active part in the major decisions, strategy and operation of the Company, although he came to Hong Kong infrequently and it was the 1st respondent who had supervised and monitored the day-to-day administration by Madam Chan.

30.  I find that the Company was set up as a marketing arm of Nu-West US in Asia.  I reject the 1st respondent’s contention that the Company was entirely separate and was free to pursue its own interest without regard to Nu-West US.  Each company had relied on the support of the other in furthering their business objectives.  The shareholders had considered the profits and losses of both companies as a whole, as evident from the business analysis prepared by the 1st respondent in 2001.  70% of the business of Nu-West US was derived from the sales of the Company.

31.  It is undeniable that the Company was established with the financial backing of Nu-West US.  As late as the Expo in late 2005, Nu-West US was assisting the Company and investing substantial sums in its operations.  It was with the permission of Nu-West US that the Company registered the trademark of RIAXIN in Hong Kong.  All the products sold by the Company were supplied by Nu-West US.  But for the fact that both entities were formed on the basis of mutual trust and confidence between the petitioner and the 1st respondent, an agreement would have been drawn up to provide for the terms on which the Company was to market and distribute the RIAXIN pads manufactured by Nu-West US.

32.  The 1st respondent’s answer to a hypothetical question put to him in cross-examination was telling.  He was asked to suppose that the petitioner had set up a new company in Hong Kong to be the new marketing arm of Nu-West US as the sales performance of the Company was unsatisfactory and whether he would find this acceptable.  He said he would object to this because this would seriously affect the business of the Company and it would be unfair to him.  This disposes of the contention that each company was free to pursue its own interest without regard to the other.

The expulsion issue

33.  The 1st respondent had advanced these grounds to justify the exclusion of the petitioner from the management of the Company since February 2006.

34.  It was claimed in the letter of the 1st respondent’s solicitors to the petitioner dated 1 June 2006 that there was an oral agreement between the parties in mid 2000 that the petitioner would manage Nu-West US and the 1st respondent would manage and be in control of all affairs of the Company, and pursuant to the alleged agreement the petitioner had never been involved in the management or decision making of the Company since incorporation.  This assertion was repeated in the notices posted by the 1st respondent in the Company on 3 June 2006, that pursuant to the oral agreement, the petitioner was an ordinary shareholder, not an ‘executive shareholder’, and that the petitioner’s only right was to inquire about the operating results and prospects from ‘the executive shareholder’.

35.  I reject all the above contentions, which were not supported by evidence.  The petitioner was entitled to and did participate in the management of the Company, prior to February 2006.  He had communicated with the 1st respondent on a daily basis regarding the business of the Company.  He had been involved in and was consulted on major decisions and strategies although not the day-to-day administration.  The distinction between an ordinary shareholder and ‘executive shareholder’ was misconceived, so was the 1st respondent’s reliance on an extract relating to limited partnerships in partnership law.  There was no justification to exclude the petitioner, a 50% shareholder, from the management of the Company.

The misappropriation issue

36.  The petitioner claimed that the 1st respondent had improperly withdrawn from the Company amounts totalling US$106,819.60, HK$250,178.05 and HK$170,519.90.  The 1st respondent claimed that after his application for a validation order was dismissed on 28 June 2006 and since 12 August 2006, he had been using his own money to finance the operations of the Company, until the Company became dormant in October 2006.

37.  The 1st respondent admitted that he started to plan for the setting up of a new company in the United States in early April 2006, before he had any reply from the petitioner if the latter was agreeable to splitting up their interests in the two companies in the manner proposed in his fax dated 9 April 2006.  He asserted that New West US was set up in a secretive manner for the benefit of the Company, and advanced two grounds to explain and justify his actions to set up a new company to produce pain-relieving pads:

(1)to ensure that the pads would be free from bacteria; and
(2)to ensure that the Company’s demands to have sufficient stock of the pads would be met.

38.  The first ground may be disposed of shortly.  The 1st respondent produced a test report from a laboratory dated 2 February 2006 stating that the samples of RIAXIN pads submitted in January 2006 failed to comply with the microbial limit in topical traditional Chinese medicines stipulated in the guidelines sanctioned by the government in Macau.  He had informed the petitioner of the test report at the time and they had discussed what should be done in the production procedures to reduce the risk of contamination.  The petitioner testified that the samples submitted within a month of this test report had passed the test and, after that, the Company continued to export RIAXIN pads to Macau for sale without any problem.  The 1st respondent admitted this in cross-examination.  He also accepted that failing the laboratory test in February 2006 was an isolated incident and did not consider there was any need to taken any action on account of this.

39.  The 1st respondent alleged in his affirmation that he had told the petitioner if bacteria-free goods could not be provided to meet the demands of the Company, he would do something on his own to ensure that the future business of the Company would not be affected.  He claimed that the petitioner raised no objection and even made a proposal that the petitioner should take over Nu-West US and the 1st respondent should take over the Company.  In cross-examination, he was unable to give even an approximate date of this important conversation.  He could not remember if what he deposed to was said in one telephone conversation.  I am not inclined to believe him.  I accept the petitioner’s evidence there was no such conversation.

40.  The first ground could provide no justification for setting up a new company in early April 2006 to produce the pads.

41.  For the second ground, it is necessary to consider the order of 500 cartons placed by the 1st respondent on 27 March 2006, whether the Company did have sufficient stock at the time, what was the anticipated future demand, and whether Nu-West US was able to meet the demands of the Company.

42.  On 23 January 2006, the Company placed a purchase order with Nu-West US for 602 cartons, to be delivered on or before 5 March 2006.  On 1 March 2006, Nu-West shipped 159 cartons under this order.  At the time the order for 500 cartons was placed on 27 March 2006, Nu-West US had not indicated that the balance of 443 cartons under the previous order would not be fulfilled and in fact on 31 March 2006, a further 196 cartons were shipped under the previous order.  Adding the 196 cartons of a value of about HK$990,000.00 to the closing inventory in March 2006 of HK$670,000.00, the level of stock would be in the region of HK$1.6 million, which was not far short of three months’ stock insisted upon by the 1st respondent as discussed below.  Further, in the petitioner’s response on 27 March 2006, he had offered to supply 200 cartons by early May 2006.

43.  The 1st respondent admitted in cross-examination he was aware that the normal production capacity of Nu-West US was 150 to 200 cartons a month.  The rate at which Nu-West US had been supplying the Company in March 2006 would seem to accord with the normal production capacity.

44.  The 1st respondent explained in his affirmation why the Company would need at least three months’ stock.  It was to meet the increasing demands in Macau, China and the Mannings Store in Hong Kong and the boost in business due to a VIP membership system to be put in place by the Company in April 2006.  In cross-examination, he clarified that the demands in China he mentioned was actually not the market in Mainland China, as the Company had not been able to export RIAXIN products to China due to the strict implementation of Good Manufacturing Practice on drugs production (GMP requirements) in China since 2004.  What he meant was just sales to Mainland tourists visiting Hong Kong.  As for the sales in Macau, he accepted that the monthly turnover in February and March 2006 was only in the region of HK$50,000.00 or HK$60,000.00.  He did not elaborate on the anticipated demand due to the VIP membership system in his affirmations or oral testimony.  So essentially, the 1st respondent was left with the anticipated demand from Mannings.

45.  The 1st respondent gave a breakdown of the anticipated increase in demands in the earlier part of his cross-examination.  He claimed that the anticipated total demand for three months was in the region of HK$4 to 5 million, made up of projected monthly sales of HK$1 to 1.2 million to Mannings, and additional monthly sales of HK$500,000.00 for Macau, Mainland tourists, and Hong Kong other than the Mannings Store.  The anticipated increase in demand from Mannings was based on his conversation with the person in charge of Mannings who allegedly said the sales could double.  The conversation was not mentioned in any of the affirmations of the 1st respondent.

46.  When the 1st respondent was asked to go through the financial statements of the Company and explain further his calculations, he changed his evidence.  He said he calculated the whole sum and did not divide up the sales or demands from various sources.  Thus, the sales volume for January to March 2006 was in the total sum of HK$3.8 million, or HK$1.2 million odd per month on average.  He worked out the inventory.  The closing inventory for March 2006 was HK$670,000.00 odd.  If he wanted three months’ stock, it should be over HK$2 million.  As the inventory in March 2006 was not enough for three months, he placed the purchase order for 500 cartons.

47.  Mr. Chan submitted that the 1st respondent would appear to have in mind the value of the purchase order for 500 cartons (HK$2.4 million odd) when he testified that three months’ stock should be worth over HK$2 million.  I am inclined to agree.  I am left with the distinct impression that the 1st respondent was tailoring his evidence to justify his claim that three months’ stock was needed.  I am very sceptical if the total anticipated demands would indeed require three months’ stock.

48.  There was no cogent explanation why the Company should need to order 500 cartons at the end of March 2006 at one go.  The 1st respondent’s prompt response on 29 March 2006 that if Nu-West US could not supply the Company, he would prepare for production in Hong Kong, was telling.  His discontent with the proposed partial delivery of 200 cartons by early May 2006 was unreasonable.  The petitioner had played into the 1st respondent’s hands when he intimidated at the end of his long fax on 3 April 2006 his desire to withdraw from the Company as the 1st respondent did not appear to trust him.

49.  I find that the second ground put forward by the 1st respondent did not justify his action in setting up New West US to produce the pads.  He had clearly acted in bad faith.  The actions taken by him in this respect, as summarised in the earlier part of this judgment, were unfairly prejudicial to the petitioner on an objective test; whether the 1st respondent had genuinely believed that he did so in the best interest of the Company is irrelevant.

50.  On 9 November 2006, the 1st respondent purportedly transferred all his shares in New West US to the Company.  I note his express instruction to his accountant in April 2006 that he was to be the sole proprietor of the new company.  He gave no credible explanation for the transfer.  This would appear to be a tactical move, to give credence to his allegation that all the subterfuges he resorted to in setting up New West US and using the Company to fund its operations, was not for his personal benefit but for the benefit of the Company.  I would attach no significance to it.

51.  Contrary to the 1st respondent’s denials, the real reason why New West US was set up was because the 1st respondent was expecting a split up with the petitioner.  He envisaged the petitioner would have Nu-West US and he would have the Company.  The pain-relieving pads would need to be produced in the United States to fetch a higher price.  As the Company would no longer obtain its supply from Nu-West US, he would need to set up his own company in the United States to produce the pads.  He did so with the funds of the Company in a surreptitious manner, without the consent of the petitioner.  This was a serious matter, not a mere question of not following “the necessary corporate formalities in some of [his] actions involving the Company and New West”, as he has sought to put a harmless explanation to this in his latest affirmation.

52.  Mr. Samuel Chan submitted that the 1st respondent had acted precipitously in setting up New West US before he had any reply from the petitioner to his proposal on 9 April 2006 to split up their interests in the two companies.  In short, the 1st respondent had jumped the gun.  The situation is similar to Allmark v. Burnham [2006] 2 BCLC 437 cited by Mr. Chan, where it was held that the actions taken by the first respondent, who had conducted himself as though he owned all the shares of the company and treated the petitioner as a ‘has been’ so far as the business was concerned, pending the conclusion of a proposed exit agreement with the petitioner, were unjustifiable in law and unfairly prejudicial to the petitioner.

The 10th Floor property issue

53.  It is the petitioner’s case there was a clear agreement or understanding between him and the 1st respondent that the 10th Floor property was to be held by the 1st respondent on trust for the Company.  Further, as the purchase price was provided by the Company, the 1st respondent held the property on a resulting trust for the Company.

54.  The 1st respondent denies there was any agreement or understanding as alleged by the petitioner.  His case is that he purchased the 10th Floor property with part of the dividend declared by the Company and distributed to him.  He had used his own funds and the property was his beneficially.

55.  According to the petitioner, prior to 2004, the Company was considering an expansion to the market in China and was studying measures to comply with the GMP requirements in order to export to China.  The 10th Floor property was intended as a packing workshop for the expansion to the China market.  The 1st respondent represented to him that it might not be a good idea for the Company to hold too many properties in its name, and suggested that this new property should be held by a shareholder on trust for the Company, and a ‘dividend’ would be paid to that shareholder to enable him to pay the purchase price.  The 1st respondent proposed initially that the petitioner should be the purchaser, but the petitioner declined and asked the 1st respondent to take up the purchase on behalf of the Company.  The 1st respondent was paid a dividend of HK$910,000.00 in early 2004 for him to purchase the property.

56.  It is not in dispute that the dividend purportedly paid to the 1st respondent was not declared by the Company in general meeting, in accordance with regulation 115 of Table A adopted as part of the articles of association of the Company.  It is common ground that to date, the petitioner has not been paid any dividend.

57.  The plan to use the property as a packing workshop that would comply with GMP requirements did not materialise.  The Company used the property as storage for some time at no charge.  The 1st respondent settled all outgoings of the property from the amount paid to him as dividend.

58.  The 1st respondent gave different accounts of how the purchase came to be made.  I find his version incredible.

59.  In his 2nd affirmation, the 1st respondent did not refer to any discussion between him and the petitioner concerning the property.  He merely stated that he decided to pay himself a dividend of HK$910,000.00 in early 2004 (in his oral evidence, he said he only took HK$900,000.00 and the petitioner took HK$10,000.00), as the Company had made a profit, that the petitioner had never shown any objection to the 1st respondent paying himself a dividend, and what he did with his dividend was entirely his own business.  He accepted though that the petitioner is also entitled to a dividend payment of HK$910,000.00.

60.  In his 3rd affirmation, he mentioned that he had discussed with the petitioner and the latter agreed to his withdrawing HK$910,000.00 as dividend.  He alleged that the petitioner was entitled to a dividend in the same amount but the petitioner chose not to take it at the time, probably due to tax reasons.  This could not be right, as the Company did not have enough cash to pay another dividend of HK$910,000.00 to the petitioner.  According to the balance sheet for the year ended 31 December 2004, the cash and bank balance stood at HK$830,400.00.  The 1st respondent acknowledged in cross-examination that in March 2004, it was not practicable for the Company to distribute dividends of HK$1.8 million to the shareholders.

61.  It was in cross-examination that the 1st respondent mentioned for the first time a discussion he had with the petitioner regarding the purchase of the 10th Floor property.  He raised the idea of purchasing this property, as the price was very low.  The petitioner asked him to use the Company to buy.  He told the petitioner as the Company already owned the 8th Floor property and the 9th Floor property, it would be better for the shareholders to buy the property jointly, with dividends distributed by the Company.  The petitioner did not think it advisable to buy the property in their joint names, and suggested the 1st respondent should buy it.  The 1st respondent declined and asked the petitioner to be the purchaser, but as the petitioner persisted, in the end the 1st respondent bought the property.

62.  His account of the discussion on the purchase of the property was not far different from the petitioner’s account, save that he still maintained when he purchased the property with a ‘dividend’ distributed only to him specially for that purpose, he did so for his own benefit and not for and on behalf of the Company.

63.  When he was cross-examined about the discussion they had on the dividend, the 1st respondent said he had told the petitioner he needed HK$900,000.00 for the purchase of the property (the purchase price was HK$780,000.00, the balance was intended for initial and future renovation expenses) and the petitioner might also get a dividend.  He did not however mention what amount of dividend might be paid to the petitioner.  His thinking at the time, which was not disclosed to the petitioner, was that if the petitioner had wanted a dividend, they would share the sum of HK$900,000.00 equally.  I find this evidence implausible.

64.  To bolster his claim that the property was not intended for the Company as a packing workshop to comply with the GMP requirements, the 1st respondent alleged that he learned about the GMP requirements and brought it to the petitioner’s attention in May 2004, whereas the sale and purchase agreement of the 10th Floor property was entered into on 23 March 2004.  This was not the case, as it would appear from contemporaneous documents in 2002 and 2003 adduced by the petitioner that the parties had been looking into the issue of complying with the GMP requirements for quite some time before the purchase of the property.

65.  On 5 March 2002, a quotation was obtained by the Company for an automated packing machine costing HK$135,000.00 and other machines for printing and packaging.  The 1st respondent initially admitted in cross-examination that the machines were for the purpose of setting up a packing workshop for the Company in Hong Kong to comply with the GMP requirements.  He retracted this admission and claimed that the quotation for machines, although obtained by the Company, was meant for Nu-West US.  He did not dispute that a detailed consultancy proposal dated 9 September 2004 was submitted to the Company by Formal Win Consultants Ltd., on measures to be taken by the Company to comply with the GMP requirements.

66.  The 1st respondent was evasive and contradictory.  I accept the petitioner’s evidence on this issue.  I find that the 1st respondent held the 10th Floor property on a constructive trust for the Company, based on the clear understanding and agreement that the Company should have the beneficial interest in the property, notwithstanding that the purchase was made in the 1st respondent’s name.  In reliance on the common intention aforesaid, the Company had acted to its detriment in providing the money for the purchase.

67.  The property was also held on a resulting trust for the Company in that it was purchased with the funds of the Company.  The amount of HK$910,000.00 or HK$900,000.00 paid to the 1st respondent was not in truth and in substance a dividend, but merely a device to enable a shareholder of the Company to purchase a property for the benefit of the Company.  In the balance sheet of the Company as at 31 March 2006 enclosed in the letter of the 1st respondent to the petitioner on 9 April 2006, there was an entry under “current assets” of account receivable being a loan to the 1st respondent of HK$900,000.00 for the purchase of the 10th Floor property.  This was not the correct treatment either, but it showed that the 1st respondent did not appear to have regarded the payment as a dividend to him.

68.  The 1st respondent had sold the 10th Floor property in May 2006.  According to him, the net proceeds amounted to HK$1,198,860.47.  The net proceeds are held on trust for the Company.  He had no right to dispose of the property on his own or retain the net proceeds for his own benefit.  This was unfairly prejudicial conduct in the affairs of the Company, and would also provide justification for winding up on the just and equitable ground.

The relief issue

69.  The primary relief sought by the petitioner is winding up rather than to have his shares bought out by the 1st respondent.

70.  Mr. Chan submitted that a buy-out order is not a practical or an effective remedy in this situation for the following reasons.

71.  Firstly, the 1st respondent has admitted he does not have the financial means to buy out the petitioner’s shares.  He has adduced no evidence on his financial ability.  He said he would need to borrow from his friends and from banks in Hong Kong and the United States to pay the purchase price.  This is of course highly relevant to the exercise of my discretion.

72.  Secondly, the Company has been dormant since about October 2006.  All the staff had left.  The solvency of the Company is in doubt, its largest creditor being Nu-West US.  It is uncertain if the Company would have the means or incentive to settle the overdue amounts of close to US$300,000.00 to Nu-West US once a buy-out order is made.

73.  Thirdly, a buy-out order would require resolution of a multitude of matters in relation to the affairs of the Company where solvency is in doubt, or would involve the court embarking on a laborious and expensive process requiring a degree of co-operation between the parties which had hitherto been lacking.  The questions of the future business relationship between the Company and Nu-West US, and the ownership of the RIAXIN and other trademarks registered by the two companies, would render the valuation of the petitioner’s shares very difficult.  The liquidator would be in a better position to carry out investigation into the relevant matters and arrive at a proper return due to the creditors and the contributories (Antoniades v. Wong [1997] 2 BCLC 419 at 427a to c).

74.  I agree with the above submissions.  It would be more appropriate to wind up the Company in these circumstances.

Orders

75.  I order the Company to be wound up.  It is not necessary to make any other order for an account against the 1st respondent as sought in the petition.  The liquidator would have vested in him all necessary powers to realise and recover assets of the Company, and to deal with claims lodged by any creditor, including Nu-West US, the 1st respondent and the supporting creditors.

76.  As costs should follow the event, I make an order nisi that the 1st respondent is to pay the petitioner’s costs in these proceedings.

 

 

 (S Kwan)
Judge of the Court of First Instance
High Court

 

Mr. Samuel Chan, instructed by Messrs. Liau, Ho & Chan, for the Petitioner

The 1st respondent, acting in person

The Official Receiver, attendance excused

 

56957-EN-2006-06-28

RE NU-WEST NATURAL PRODUCTS CORP LTD

HTML content